Eric Verdin
- Geriatrics and Gerontology top 0.01%
- Sirtuins and Resveratrol in Medicine 82
- Virology top 0.05%
- HIV Research and Treatment 68
- Aging top 0.05%
- Physiology top 0.02%
- Adipose Tissue and Metabolism 41
- Physiology top 0.05%
- Adipose Tissue and Metabolism 41
-
- Histone Deacetylase Inhibitors Research 55
- Protein Degradation and Inhibitors 27
-
- Immune Cell Function and Interaction 36
-
- HIV/AIDS drug development and treatment 33
-
- Autophagy in Disease and Therapy 28
- Co-authors
- John C. NewmanMélanie OttBrian J. NorthWolfgang FischleMatthew D. HirscheyCarine Van LintStéphane EmilianiBjoern Schwer
- Journals
- Journal of Biological Chemistry (17 papers)Journal of Virology (16 papers)Proceedings of the National Academy of Sciences (12 papers)
- Partner nations
- United StatesGermanyBelgium
In The Last Decade
Eric Verdin
277 papers receiving 47.1k citations
Hit Papers
Peers
Comparison fields: 5 of 187
- Geriatrics and Gerontology 10.8k
- Virology 6.6k
- Aging 1.4k
- Physiology 2.5k
- Physiology 11.0k
Countries citing papers authored by Eric Verdin
This map shows the geographic impact of Eric Verdin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Verdin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Verdin more than expected).
Fields of papers citing papers by Eric Verdin
This network shows the impact of papers produced by Eric Verdin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Verdin. The network helps show where Eric Verdin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eric Verdin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 11 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 4 | |
| 4 | 2022 | 9 | |
| 5 | 2021 | 2 | |
| 6 | 2021 | 75 | |
| 7 | 2021 | 3 | |
| 8 | 2020 | 111 | |
| 9 | 2020 | 9 | |
| 10 | 2020 | 20 | |
| 11 | Mitochondrial Deacetylase Sirt3 Reduces Vascular Dysfunction and Hypertension While Sirt3 Depletion in Essential Hypertension Is Linked to Vascular Inflammation and Oxidative Stressbreakdown → | 2019 | 267 |
| 12 | 2019 | 3 | |
| 13 | 2017 | 4 | |
| 14 | 2017 | 97 | |
| 15 | 2015 | 124 | |
| 16 | Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitorbreakdown → | 2012 | 1329 |
| 17 | 2009 | 69 | |
| 18 | 2007 | 312 | |
| 19 | 2007 | 58 | |
| 20 | 2005 | 377 |
About Eric Verdin
Eric Verdin is a scholar working on Geriatrics and Gerontology, Virology and Aging, having authored 279 papers that have together received 47.7k indexed citations. Recurring topics across this work include Sirtuins and Resveratrol in Medicine (82 papers), HIV Research and Treatment (68 papers), Histone Deacetylase Inhibitors Research (55 papers), Adipose Tissue and Metabolism (41 papers), Immune Cell Function and Interaction (36 papers), HIV/AIDS drug development and treatment (33 papers), Autophagy in Disease and Therapy (28 papers) and Protein Degradation and Inhibitors (27 papers). The work is most often cited by research in Geriatrics and Gerontology (10.8k citations), Virology (6.6k citations) and Aging (1.4k citations). Eric Verdin has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include John C. Newman, Mélanie Ott, Brian J. North, Wolfgang Fischle, Matthew D. Hirschey, Carine Van Lint, Stéphane Emiliani, Bjoern Schwer, Samuel Dequiedt and Warner C. Greene. Their work appears in journals such as Journal of Biological Chemistry, Journal of Virology, Proceedings of the National Academy of Sciences, Cell Metabolism and PLoS Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.